# Retrolaminar Block Improves Postoperative Gastrointestinal System Functions:

> **NCT06787898** · NA · COMPLETED · sponsor: **Elazıg Fethi Sekin Sehir Hastanesi** · enrollment: 60 (actual)

## Conditions studied

- Retrolaminar Block
- Percutaneous Nephrolithotomy (PCNL)

## Interventions

- **OTHER:** Group R: retrolaminar block performed group
- **OTHER:** Group C - Placebo

## Key facts

- **NCT ID:** NCT06787898
- **Lead sponsor:** Elazıg Fethi Sekin Sehir Hastanesi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-22
- **Primary completion:** 2025-02-12
- **Final completion:** 2025-02-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06787898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06787898, "Retrolaminar Block Improves Postoperative Gastrointestinal System Functions:". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06787898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*